Table 4.
Number of Subjects | 1–5 Years (Tacro + MMF) |
>5 Years (Tacro + MMF) |
1–5 Years (Tacro) |
>5 Years (Tacro) |
|
---|---|---|---|---|---|
72 | 44 | 10 | 18 | ||
Therapeutic range | <3 µg/L | NA | - | NA | - |
3–5 µg/L | NA | 3 (6.8%) | NA | 2 (11.1%) | |
>5 µg/L | NA | 41 (93.2%) | NA | 16 (88.9%) | |
<4 µg/L | - | NA | - | NA | |
4–6 µg/L | 13 (18.1%) | NA | 6 (60.0%) | NA | |
>6 µg/L | 59 (81.9%) | NA | 4 (40.0%) | NA |
MMF—mycophenolate mofetil; Tacro—tacrolimus; NA—not applicable.